Cardiovascular effects of sodium-glucose cotransporter 2 inhibitors: multiple actions.
a 12 Dionyssiou St , Thessaloniki , 546 34 , Greece ;
Niki
N
Katsiki
b Second Propedeutic Department of Internal Medicine , Medical School, Aristotle University of Thessaloniki, Hippocration Hospital , Thessaloniki , Greece ;
Vasilios G
VG
Athyros
c Department of Clinical Biochemistry , Royal Free Hospital Campus, University College London Medical School, University College London (UCL) , Pond Street , London NW3 2QG , UK.
Dimitri P
DP
Mikhailidis
D003924:Diabetes Mellitus, Type 2; D005947:Glucose; D007004:Hypoglycemic Agents; D012964:Sodium; D051297:Sodium-Glucose Transporter 2
D007004:Hypoglycemic Agents; D051297:Sodium-Glucose Transporter 2; D012964:Sodium; D005947:Glucose